Q1: Why is it necessary to evaluate the environmental persistence of live biotherapeutics? A: Assessing environmental persistence is a critical regulatory requirement. It ensures that genetically modified or therapeutically enhanced live microbes do not pose unintended colonization, contamination, or biosafety risks when shed into the environment.

Q2: What methodologies do you use to test microbe survival on different surfaces? A: We utilize controlled desiccation chambers and time-course viability assays across various fomite materials (e.g., stainless steel, plastics). Our comprehensive surface survival & environmental persistence risk assessment provides robust data on the decay rates and half-lives of your specific strains.

Q3: Can this data be used to support regulatory submissions like IND or NDA? A: Yes. The rigorous data generated through our physical stability and persistence assays is specifically designed to meet the stringent biosafety guidelines of major regulatory agencies (such as the FDA and EMA) for LBP applications.